Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_assertion type Assertion NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_head.
- NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_assertion description "[These findings suggest that mutations in the RARalpha /E-domain of the PML/RARalpha chimeric gene may confer clinical resistance to ATRA therapy in patients with APL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_provenance.
- NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_assertion evidence source_evidence_literature NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_provenance.
- NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_assertion SIO_000772 9657734 NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_provenance.
- NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_assertion wasDerivedFrom befree-2016 NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_provenance.
- NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_assertion wasGeneratedBy ECO_0000203 NP1398941.RAP9urxgLOpUgdLah1vS7_zVi8qzEk1WkeUMmsmxHPEb0130_provenance.